Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amphastar Pharmaceuticals

23.78
+0.56002.41%
Post-market: 24.000.2200+0.93%19:39 EDT
Volume:321.59K
Turnover:7.62M
Market Cap:1.11B
PE:8.88
High:23.89
Open:23.09
Low:23.09
Close:23.22
52wk High:53.96
52wk Low:20.39
Shares:46.50M
Float Shares:35.34M
Volume Ratio:0.74
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.68
EPS(LYR):3.29
ROE:18.32%
ROA:7.31%
PB:1.46
PE(LYR):7.22

Loading ...

Stock Track | Amphastar Pharmaceuticals Soars 9.26% on FDA Approval for Generic Iron Sucrose Injection

Stock Track
·
Aug 11

Stock Track | Amphastar Pharmaceuticals Soars 8.81% Pre-market on FDA Approval for Generic Iron Sucrose Injection

Stock Track
·
Aug 11

Stock Track | Amphastar Pharmaceuticals Soars 8.81% Pre-market on FDA Approval for Generic Iron Sucrose Injection

Stock Track
·
Aug 11

Amphastar Pharmaceuticals Inc -Announces FDA Approval for Iron Sucrose Injection, Usp

THOMSON REUTERS
·
Aug 11

Amphastar Pharmaceuticals Secures FDA Approval for Generic Iron Sucrose Injection for Treating Iron Deficiency Anemia

Reuters
·
Aug 11

Stock Track | Amphastar Pharmaceuticals Soars 11.79% as Q2 Earnings Surpass Expectations

Stock Track
·
Aug 08

Stock Track | Amphastar Pharmaceuticals Soars 5.41% on Earnings Beat Despite Revenue Dip

Stock Track
·
Aug 08

Amphastar Pharmaceuticals Q2 2025 Earnings Call Summary and Q&A Highlights: Baqsimi Drives Growth Amid Competitive Pressures

Earnings Call
·
Aug 08

Stock Track | Amphastar Pharmaceuticals Soars 6.15% After-Hours on Q2 Earnings Beat and Expansion Plans

Stock Track
·
Aug 08

Amphastar Pharma Q2 Adj. EPS $0.85 Beats $0.76 Estimate, Sales $174.414M Beat $174.249M Estimate

Benzinga
·
Aug 08

Director Floyd F. Petersen Reports Disposal of Common Shares of Amphastar Pharmaceuticals Inc

Reuters
·
Aug 05

Amphastar Pharmaceuticals Files Initial Statement of Beneficial Ownership for Director David Russell Gaugh

Reuters
·
Jul 23

Amphastar Pharmaceuticals Inc. Expands Board, Appoints David Gaugh as New Independent Director

Reuters
·
Jul 22

Amphastar Pharmaceuticals to Quadruple U.S. Manufacturing Capacity at Rancho Cucamonga Headquarters

Reuters
·
Jul 15

Director Floyd F. Petersen Reports Disposal of Common Shares of Amphastar Pharmaceuticals Inc

Reuters
·
Jul 04

Director Floyd F. Petersen Reports Disposal of Common Shares of Amphastar Pharmaceuticals Inc

Reuters
·
Jun 05

Amphastar Pharmaceuticals Inc. Unveils Presentation on Innovative Product Development and Integrated Business Strategies at Healthcare Conference

Reuters
·
Jun 04

Amphastar Pharmaceuticals Cut to Neutral From Overweight by JP Morgan

Dow Jones
·
May 12

JPMorgan Downgrades Amphastar Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $30 From $45

MT Newswires Live
·
May 12

U.S. RESEARCH ROUNDUP-Amphastar Pharmaceuticals, Comstock, Range Resources

Reuters
·
May 12